Overview
At GenEvo, we are driven by the vision of transforming the medical landscape through our innovative gene-editing solutions. Our flagship product, EvoEdit, is designed to target genetic disorders with exceptional precision, offering hope to patients with conditions that currently have limited treatment options. Over the past 18 months, we have successfully developed our prototype and conducted preliminary trials, demonstrating a significant efficacy rate. As the biotech industry continues to explode, with the global gene editing market projected to reach $8.4 billion by 2027, we recognize the urgency to scale our operations to meet this rising demand. However, to advance our product to the next stage, we need $285,000 in funding. This investment will specifically enable us to enhance our R&D capabilities, perform extensive clinical trials, and initiate our marketing strategy focused on gaining traction within various healthcare sectors. Our team has the expertise, but we need the financial backing to fulfill our potential in this high-growth market. this is a founder-led project looking for investment, operating support and long-term business discipline. GenEvo is pioneering advance…
Use of funds
The $285,000 investment will be allocated as follows:
- Research and Development: $120,000 for further product enhancements and clinical trials.
- Regulatory Compliance: $75,000 to navigate necessary approvals and ensure our product meets safety standards.
- Marketing and Sales: $60,000 to develop marketing materials and initiate outreach to potential healthcare partners.
- Operational Costs: $30,000 to cover essential operational expenses during this growth phase.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.